Multicellular 3D cancer cell culture (spheroids) resemble to in vivo tumors in terms of shape, cell morphology, growth kinetics, gene expression and drug response. However, these characteristics cause very limited drug penetration into deeper parts of the spheroids. In this study, we used multi drug resistant (MDR) ovarian cancer cell spheroid and in vivo tumor models to evaluate the codelivery of paclitaxel (PCL) and a potent NF-κB inhibitor curcumin (CUR). PCL and CUR were co-loaded into the polyethylene glycol-phosphatidyl ethanolamine (PEG-PE) based polymeric micelles modified with Transferrin (TF) as the targeting ligand. Cytotoxicity, cellular association and accumulation into the deeper layers were investigated in the spheroids and compared with the monolayer cell culture. Comparing to non-targeted micelles, flow cytometry and confocal imaging proved significantly deeper and higher micelle penetration into the spheroids with TF-targeting. Both in monolayers and spheroids, PCL cytotoxicity was significantly increased when codelivered with CUR in non-targeted micelles or as single agent in TF-targeted micelles, whereas TF-modification of co-loaded micelles did not further enhance the cytotoxicity. In vivo tumor inhibition studies showed good correlation with the 3D cell culture experiments, which suggests the current spheroid model can be used as an intermediate model for evaluation of co-delivery of anticancer compounds in targeted micelles.
Introduction
In cancer research, cell-based assays are widely used for screening of drug candidates and drug delivery systems. Especially, 2D monolayer culture models have become a standard and regular model for cytotoxicity assays due to their simplicity and suitability for highthroughput techniques. However, monolayer or suspension cell cultures are lack of 3D architecture and extracellular matrix, which are two of the main definer properties of the in vivo tumors (Cukierman et al., 2001) . Besides in vivo tumor models, an effective and easy approach in studying the properties of tumors is to culture cancer cells in 3D spheroids. A spheroid is a collection of cancer cells held together by a variety of cell-cell junctions, surface membrane microprojections and extracellular matrix (Sutherland, 1988, Owen and Shoichet, 2010) .
3D cancer cell cultures (cancer cell spheroids) have gained a lot of interest after their first application in cancer research (Sutherland et al., 1971) . Cancer cell spheroids have found to better reflect the cancer tissue complexity, pathophysiology and microenvironment, thus they better resemble the in vivo tumor tissues with regard to tumor shape, cell morphology, growth kinetics, gene expression and drug response (Hall et al., 2004 , Goodman et al., 2008 . Their 3D structure consisting of extensive amount of ECMs causes a complex interaction with cell-to-cell and microenvironment (Berrier and Yamada, 2007) . They also tend to show similar growth kinetics to in vivo tumors (Hamilton, 1998) . The outer-region cells of a spheroid are actively proliferating, while inner-region cells are in non-proliferative state. Spheroids also contain arrested cells in all phases of the cell cycle (Sutherland, 1988) . These properties are crucial for testing anticancer therapeutics (Freyer and Sutherland, 1980 , Venkatasubramanian et al., 2008 , Wartenberg et al., 2002 . It is also important to mention that relative to 2D cultures, spheroids have become a great tool for studying the penetration of anticancer drugs into tumor tissue because they provide the necessary architecture to perform such studies (Minchinton and Tannock, 2006) . This combination of heterogeneous cell populations and penetration-limiting properties can cause central necrosis and regions of hypoxia in large spheroids, thus they demonstrate high similarities with avascular tumor microregions and micrometastases (Sutherland, 1988 , Friedrich et al., 2007 .
It has been noted that the response of spheroids to cytotoxic drugs varies from that of monolayer cell culture not only because of limited penetration (Kerr et al., 1988) but also due to dissimilarity in gene expression and cell-cell communication (Mehta et al., 2012) . The efflux transporter protein associated with multidrug resistance, P-glycoprotein (P-gp), is upregulated in the G0/G1 phase cells located at the core of a spheroid but normal levels are present in the G2/M arrested cells (Wartenberg et al., 2002) . A number of metabolic and synthetic genes are also upregulated in spheroids (Chang and Hughes-Fulford, 2009 ). Angiogenesis factors, such as the vascular endothelial growth factor, are also differently expressed depending on the type of culture (Sonoda et al., 2003) . In conclusion, resistance to anticancer drugs, known as multidrug resistance (MDR), is dependent on both biochemical and physical obstructions in spheroids such as overexpressed efflux pumps (i.e. P-gp), upregulated pathways (i.e. NF-κB and PI3K) and limited penetration of drugs into the spheroid (Jang et al., 2003 , Durand, 1990 .
Paclitaxel (PCL), one of the most prescribed conventional chemotherapeutic agents, acts as microtubule stabilizer and blocks cancer cells in the G2/M phase, thus preventing them from mitosis (Wang et al., 2000) . It is also an apoptosis inducer in cancer cells (Sugimura et al., 2004) . One of the main drawbacks of its use is that it is also a substrate of P-gp and treatment with PCL induces the overexpression of the efflux pump in the cancer cells (Jang et al., 2001) . NF-κB is a transcription factor that controls the expression of genes involved in a number of physiological responses including differentiation, inflammation, and apoptosis (Pahl, 1999) . It also has a role of upregulation of MDR1 that codes the P-gp (Gupta et al., 2010) . The PI3K/Akt pathway is also another over-activated pathway in a wide range of tumor types and therefore its over-activation leads to increased cancer-cell survival, proliferation, and growth and it also promotes NF-κB activity (Romashkova and Makarov, 1999) , all affects the success of the chemotherapy with PCL.
Curcumin (CUR), a polyphenol known as diferuloylmethane, has several functions including anticancer activity (Anand et al., 2008 , Anand et al., 2010 , Yallapu et al., 2012 , Nair et al., 2012 . But most importantly, CUR is able to downregulate both the PI3K/Akt and NF-κB pathways independent of each other, thus it can acts as a mediator of chemoresistance by sensitizing cancer cells to a conventional chemotherapeutic agents .
The investigation of doxorubicin-loaded and anti-cancer antibody 2C5-modified micelle effect on resistant cancer cell spheroid model has been accomplished previously in our lab . We have also shown that transferrin (TF)-modified PEG-PE (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000]) micelles co-loaded with PCL and CUR demonstrate an enhanced cancer cell killing in the monolayer culture (Abouzeid et al., in press ). In the current study, we wanted to evaluate the effect of the micellar PCL/CUR and TF as the targeting ligand on resistant ovarian cancer spheroids and in vivo tumors. We hypothesized that (i) micellar encapsulation and delivery would enhance the spheroid/tumor penetration and toxicity of the drugs, and (ii) adding TF as the targeting and endocytosis enhancing ligand would increase the penetration of the micellar systems into the spheroids/tumors. With this in mind, PEG-PE-based mixed micelle formulations co-loaded with PCL and CUR and containing vitamin E as the solubility enhancer were prepared, and TF was used as the targeting ligand. Following micelle characterization, cytotoxicity of these micelle formulations was investigated on resistant ovarian cancer cell line NCI-ADR-RES spheroids compared to monolayers. Cellular association and penetration abilities and apoptosis enhancing properties of the formulations on spheroids were also evaluated. The antitumor activity of the formulations was also tested in mice bearing PCL-resistant ovarian SK-OV-3TR tumor. For better comparison, we have attempted to produce SK-OV-3TR spheroids, but in agreement with what was reported previously in many publications (Vinci et al., 2012 , Loessner et al., 2010 , Sodek et al., 2009 , we faced inconsistent spheroid formation by SK-OV-3TR cells under various conditions, which let us to use another resistant ovarian cancer cell line (NCI-ADR-RES), which has the properties close enough to those of the SK-OV-3TR cells, i.e. apoptosis initiator death receptor CD95 levels and response to the ligand (Algeciras-Schimnich et al., 2003) , for spheroid studies.
Materials and Methods

Materials
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000] (PEG 2000 -PE) was purchased from Corden Pharma International (Plankstadt, Germany). 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rhodamine-PE) were from Avanti Polar Lipids (Alabaster, AL, USA). pNP-PEG 3400 -pNP was purchased from Laysan Bio (Arab, AL). Curcumin (CUR), vitamin E and human holo-transferrin (TF) were purchased from Sigma (St. Louis, MO, USA). Paclitaxel (PCL) was from LC Laboratories (Woburn, MA). Accumax ® was from Innovative Cell Technologies, Inc. (San Diego, CA). The CellTiter-Glo ® luminescent cell viability assay kit was from Promega (Fitchburg, WI). All other reagents were of analytical grade.
Cell culture and spheroid formation
Human MDR ovarian cancer NCI-ADR-RES cells (National Cancer Institute, Frederick, MD, USA) were grown at 37°C at 5% CO2 in DMEM supplemented with 50 U/mL penicillin, 50 (µg/mL streptomycin and 10% FBS (v/v). Multicellular NCI-ADR-RES cancer cell spheroids prepared by liquid overlay method . Briefly, serum free DMEM medium with 1.5% (w/v) agar was prepared and sterilized. 50 µL of the agar solution were added to the bottom of each well of the 96 well plates to prevent cell adhesion onto the well surface. Plates were allowed to cool down for 45 minutes before use. NCI-ADR-RES cells were trypsinized, counted and then seeded at the density of 12,000 cells/ well. Plates were centrifuged for 15 min at 1,500 rcf at 24°C. Spheroid formation was continuously followed using Nikon Eclipse E400 microscope (Nikon Inc., Melville, NY) with the Spot camera and Spot Advanced™ software (Spot Imaging, Sterling Heights, MI). When the spheroids are formed and dense (after 3-5 days), they were treated with the formulations for various purposes.
SK-OV-3TR cells, PCL-resistant variant of SK-OV-3 human ovarian adenocarcinoma cell line, were a kind gift from Dr. Duan Zhenfeng (MGH, Boston, MA). To produce SK-OV-3TR spheroids, hanging drop method were also tried in addition to liquid overlay method with modifications.
Micelle preparation
PCL and/or CUR drug-loaded mixed micelles were prepared by the thin film hydration method. PCL (1 mg/ml in 0.1% acetic acid-methanol solution) and/or CUR (2 mg/ml in 0.1% acetic acid-methanol solution) at various weight % of the polymer were added to PEG 2000 -PE and vitamin E (89:11 molar ratio) solution in chloroform. The organic solvents were removed by the rotary evaporation and a thin film of drug/micelle-forming material mixture was formed. This film was further dried overnight in freeze-dryer to remove any residuals of organic solvents (Freezone 4.5 Freeze Dry System, Labconco, Kansas City, MO). Drug-loaded mixed micelles were formed by resuspending the film in phosphate buffered saline (PBS) pH 7.4, to give the final concentration of micelle forming materials of 5 mM in all formulations. Excess non-incorporated drugs were separated by filtration through a 0.2 µm syringe filter before characterization. Micelle size was measured by the photon correlation spectroscopy (PCS) using a N4 Plus Submicron Particle System (Coulter Corporation, Miami, FL, USA). Zeta potential values of the micelles were determined by using Zeta Plus Particle Analyzer (Brookhaven Instruments Corp, Santa Barbara, CA). Critical micelle concentration (CMC) of the micelles was estimated by standard Pyrene method (Zhao et al., 1990) as described in (Sawant et al., 2008) .
Preparation of targeted micelles
To obtain targeted micelles, TF was reacted with pNP-PEG 3400 -PE (Torchilin et al., 2001) . Briefly, required amount of pNP-PEG 3400 -PE in chloroform was added into the round bottom flask and polymer film was formed after removing the solvent by rotary evaporation followed by overnight drying under vacuum. The film was hydrated and vortexed first with citrate-buffered saline (CBS) pH 5.0 to prevent early hydrolysis of pNP distal groups. After forming micelles, TF solution in PBS (pH 7.4) was added to the mixture, and the pH was adjusted to 8.5 with NaOH. Molar ratio of pNP groups to TF was kept at 2:1. Reaction time was overnight at room temperature to allow sufficient TF conjugation and the complete hydrolysis of the unreacted pNP groups at the higher pH. TF-micelles were then dialyzed using a 100,000 MWCO cellulose ester membrane against PBS (pH 7.4) for 4 hours to insure the complete removal of the unconjugated TF. TF conjugated micelles were mixed and co-incubated with drug loaded PEG-PE micelles at 1% mole ratio of pNP-PEG 3400 -PE to PEG2000-PE for 4 hours at room temperature. Conjugation efficiency of TF was measured using a micro BCA kit (Pierce, Rockford, IL) according to the manufacturer's instructions. Protein content was determined by comparing TF-modified micelles to a known concentration of TF standards. Absorbances from TF-modified micelle samples were normalized with empty non-targeted micelle samples at the same lipid concentration.
Drug solubilization efficiency of the micelles
Drug incorporation efficiency was measured by a validated RP-HPLC method using a Hitachi Elite LaChrome HPLC system equipped with an autosampler (Pleasanton, CA) and diode array detector. Xbridge C18 (4.6 mm x 250 mm) reverse phase column (Waters Corporation, Milford, MA) was eluted with 60:40 (v/v) acetonitrile:water mobile phase at flow rate of 1 ml/min. PCL was detected at a wavelength of 227 nm, while CUR was detected at 420 nm. Sample injection volume was kept constant at 50 µl and the sample run time was 8 min. The concentration of the drug was determined by measuring the area under curve of the corresponding peaks. Standard curves obtained using the known amounts of drugs in mobile phase, were used to determine the concentration of the incorporated drug in micelles. Drug-loaded micelles were filtered to remove non-incorporated drugs and diluted in the mobile phase to disrupt the micelle structure and release the incorporated drugs for detection. All samples were analyzed in triplicate. Validation parameters were specificity, linearity, precision (repeatability, intermediate precision and reproducibility), accuracy and stability.
Associatian of micelles with cancer cell spheroids compared to monolayers
Cellular association of TF-targeted or non-targeted micelles was assessed by flow cytometry after 4 hours incubation with resistant ovarian cancer cell monolayers. Briefly, NCI-ADR-RES cells were seeded in 12-well plates at a density of 80,000 cells/well and grown for 24 hours. Then cells were treated with rhodamine-labeled (1% mol) micelle formulations at 1 mg/mL lipid concentration in serum complete media (10% FBS). Same formulations and lipid concentrations were used for investigating the cellular association patterns with spheroids after 1, 4 and 6 hours of incubation time. For monolayers, after the incubation time cells were trypsinized and detached from the wells. Cell suspensions were analyzed with FACSCalibur flow cytometer (Beckton Dickinson, Franklin Lakes, NJ) using 488 nm blue laser for excitation and FL2 channel (585/42 nm) for recording. Cells were gated using forward versus side scatter to gate 10,000 events after excluding debris and dead cells.
Micelle association in spheroids was investigated after incubation of 5-day-old spheroids with rhodamine-labeled micelles. At the determined incubation times, 5 spheroids as one replicate were collected into the tubes to achieve necessary cell number. The spheroids were washed two times with PBS. Following removal of the remaining PBS, AccuMax ® cell detachment solution was added and tubes were incubated for 10 minutes at 37°C on the horizontal shaker with occasional pipetting. After dispersing of the spheroids into single cells, FBS was added into the tubes to inhibit the AccuMax ® activity. Cells were centrifuged and dispersed in ice-cold PBS, then immediately analyzed with flow cytometer using the same settings described above. All flow cytometry experiments with monolayers and spheroids were triplicate.
Distribution of micelles in spheroids
Distribution of rhodamine throughout the spheroids was analyzed after 1, 4 and 6 hours incubation of 5-day-old spheroids with rhodamine-labeled non-targeted and TF-targeted micelles in the complete media by a Zeiss LSM 700 confocal microscope. Spheroids were harvested and fixed in 4% paraformaldehyde, then placed in 16-well glass chamber slides (Nunc™ Lab-Tek™ Chamber Slide System, USA). Z-stack images of spheroids starting at the apex of each spheroid were collected with 10 µm intervals using 555 nm laser at 1.2%. All images were taken using a 10× objective. Images were analyzed using Image-J software with Fiji package (NIH, Bethesda, MD, version 1.49b). Maximum intensity Z-projection images were also taken to indicate the rhodamine intensity differences in the groups. To evaluate the penetration profiles, rhodamine intensity in the center of the each Z-stack were calculated using corrected integrated pixel density and plotted against the depth.
Transferrin receptor expression in spheroids
Transferrin receptor (TfR) levels in monolayers and spheroids were compared using flow cytometry. NCI-ADR-RES cells were seeded as monolayers in 6-well plates at a density of 4×10 per well. After 24 hours, the cells were washed three times with ice-cold PBS, detached by mechanical scrapping and resuspended in 0.5% bovine serum albumin in PBS. The cell suspensions were incubated either with fluorescein isothiocyanate-labeled (FITC) anti-transferrin receptor monoclonal antibody (Clone B-G24, Abcam, MA, USA) or FITClabeled isotype control at +4°C at the ratio recommended by the manufacturer. After 30 minutes of incubation, the cells were washed with 0.5% bovine serum albumin in PBS and analyzed by flow cytometry. 488 nm blue laser was used for excitation and FL1 channel was used for recording of 10,000 events. To investigate the TfR levels in spheroids, NCI-ADR-RES spheroids were grown, and at different days were harvested and dissociated with same method as above using AccuMax ® cell detachment solution. Additionally, spheroids were incubated with the TfR antibody prior to dissociation for 1 hour and then analyzed by flow cytometry. After the single cells were obtained from spheroids, same procedures were done as with monolayers.
cellular viability in spheroids compared to monolayers
The in vitro cytotoxicity of the different micellar formulations was investigated against NCI-ADR-RES spheroids compared to monolayers. For monolayer cell viability, Cell Titer Blue ® (Promega, Madison, WI) viability assay was used according to the manufacturer's protocol. Briefly, cells were seeded into the 96-well plates at a density of 3000 cells/well and grown for 24 hours before treatment. After incubation with the formulations in serum complete media for 72 hours, wells were washed twice and Cell Titer Blue ® reagent was added into the wells according to the manufacturer's protocol. Obtained cellular viability values were graphed against PBS treated cells as controls.
Cellular viability of the spheroids was determined after 72 hours treatment of 3-day-old spheroids. After the treatment with different formulations, drug concentrations and combinations, all the media from the corresponding wells along with the spheroids were collected and placed in a centrifuge tube. Five spheroids were collected as one replicate to increase the sensitivity. To disperse the spheroids into single cells, same method described with AccuMax ® cell detachment solution was used. Obtained cells were centrifuged and supernatants were discarded. Complete DMEM and CellTiter-Glo ® reagent at 1:1 volume ratio was added into the tubes and cells were incubated for 20 minutes for complete cell lysis. Luminescence was measured using multiplate reader by transferring 100 µL of the solution into 96 well black-walled plates. Cytotoxicity data in the figure are presented as the mean ± standard deviation. PBS-treated cells were taken as controls to calculate % cell viability, and the treatment was carried out in triplicate and at least 3 different assays.
Detection of phosphotidylserine externalization
Phosphotidylserine (PS) externalization from inner membrane to outer membrane as an indicator of apoptosis was investigated by flow cytometry using annexin V and propidium iodide (PI) (Vermes et al., 1995) . NCI-ADR-RES monolayers and 5-day-old spheroids were treated with 5 µM CUR and/or 0.80 µM PCL for 72 hours. Briefly, cells were collected from monolayers or spheroids as single cells and washed twice with PBS, resuspended in annexin binding buffer and analyzed using Alexa Fluor ® 488 annexin V/Dead Cell Apoptosis Kit with Alexa Fluor 488 annexin V and PI (Molecular Probes, Eugene, OR, USA) according to the manufacturer's protocol.
Tumor inhibition studies
Possible correlation between the spheroid model and in vivo model of resistant ovarian cancer was investigated on tumors of SK-OV-3TR cells. TF-modified and non-modified micelles containing CUR and/or PCL were used to investigate the tumor inhibition efficacy of formulations. 6-8 weeks old nude mice were used in the experiments. Weights of the mice were monitored throughout the study as an indicator for toxicity and intolerability of the formulations. When the SK-OV-3TR cells reached to 70% confluency, they were trypsinized and harvested. Cells were then counted and 3 million cells were re-suspended in 200 µL of Matrigel:PBS solution (1:1, v/v). The cell suspensions were injected subcutaneously over the right flank of the animal. Tumors were allowed to grow for approximately 14 days post tumor inoculation and tumor volume was measured regularly. Mice were randomly split into 4 different groups upon tumor reaching 200 mm 3 All formulations were administered intraperitoneally due to the high injection volume (~500µL) at a dose of 25 mg/kg CUR and 10 mg/kg PCL every 3 days. The dose ratio of CUR:PCL was 2.5:1 w/w as determined by in vitro assays. Mice were monitored for changes in their body weight and tumor volumes measured daily with the same Vernier caliper. The measurements were taken in two perpendicular dimensions and tumor volumes were calculated by applying the formula (L x W )×1/2, where L is the longest dimension and W is the dimension perpendicular to L. All animals were sacrificed when the control group tumor volumes reached 1000 mm 3 Tumors from the mice were also collected and weights were recorded.
Results and Discussion
Characterization of co-loaded micelles
All the TF-targeted or non-targeted micelle formulations have the hydrodynamic diameter ranging from 15-20 nm. Zeta potential values of the targeted and non-targeted micelles were −18.9±0.9 mV and −27.7±1.7 mV, respectively. Attachment of TF targeting moiety did not change the micelle size significantly, as reported previously (Sawant et al., 2013) . Also, encapsulation of PCL and CUR alone or together did not cause significant differences in the micelle size. CUR and PCL were effectively co-encapsulated into the both TF-targeted and non-targeted micelles at concentrations of 1216.7±82.3 (µg/mL (3.3±0.2 mM) and 482.5±37.3 (µg/mL (0.56±0.04 mM), respectively. The weight ratio between the co-loaded CUR and PCL was approximately 2.5:1. There was no significant difference between the encapsulated drug amounts in the micelles when the individual drugs were used. Moreover, TF-modification did not affect the solubilized drug amounts in the micelle formulations. Both CUR and PCL are water insoluble drugs thus, to achieve higher co-loading values vitamin E was added to the formulations. It has been reported that vitamin E acts as a solubility enhancer for the hydrophobic drugs by increasing the hydrophobicity and the volume of the micelle core, resulting in the higher encapsulation values of the non-soluble drugs (Dabholkar et al., 2006 , Sawant et al., 2008 , Torchilin, 2005 .
The TF conjugation efficiency to the micelles was determined by micro BCA assay using TF instead of BSA as the protein standard after the dialysis of TF-PEG 3400 -PE micelles. The amount of actual TF in the final formulations was calculated as 0.64 mol% of the total lipids, which corresponds to TF concentration of 32 µM. The CMC value for PEG-PE/ vitamin E micelles was 1.66×10 −5 M, in correspondence with the previously reported CMC values for mixed PEG-PE micelles (Lukyanov and Torchilin, 2004 , Mu et al., 2005 , Musacchio et al., 2009 ).
Spheroid Formation
For cancer cells, to build up spheroids, the main requirement is to create forces to prevent cell adhesion to the container wall and thus, generate an environment, which helps the cells to adhere themselves. Several spheroid production methods have been described in literature as spinner flasks (Song et al., 2004 , Nyberg et al., 2005 , hanging drops (Kelm et al., 2003) , matrix culture (Lee et al., 2007) , low attachment plates (Vinci et al., 2012) , scaffold-based culture (Fischbach et al., 2007) and rotary cell culture (Khaoustov et al., 1999) . However, every mentioned technique has limitations such as requirement of specialized equipment, variation in cell number and spheroid size, high shear forces, intensive labor and most importantly difficulties in scale-up and massive production processes. Liquid overlay technique which involves creation of non-adhesive surfaces in cell culture plates and petri dishes by coating of poly-HEMA (hydroxyethyl methacrylate) Kubbies, 2006, Hoevel et al., 2004) or agar (Friedrich et al., 2009 ) have been regularly used to produce cancer cell spheroids. The liquid overlay technique with agar coated 96 well plates is proven to give unified, reproducible and dense tumor cell spheroids when compared to the other previously mentioned methods but the main the advantages were obtaining single spheroid/ well for easy handling and massive spheroid production numbers for high-throughput screening tests. In our study, the spheroid production yield was 94.8±2.3% with intra-plate coefficient of variation of 2.45%.
According to the classification that has been establish by Ivascu and Kubbies (Ivascu and Kubbies, 2007 ) the resulted spheroids can be classified as tight spheroids with sharp edges and dense structures. The resulted NCI-ADR-RES spheroids have diameters of 1259.0±70.8, 729.0±46.8, 523.0±20.4, 550.3±21.0 and 544.3±23.5 µm at day 0, 1, 3, 5 and 7, respectively. Even though spheroid sizes larger than 500 µm can indicate a central secondary necrosis and hypoxic regions (Kunz-Schughart, 1999), Mikhail et al. demonstrated than those properties can also be cell type dependent, while hypoxic and necrotic core structure could be seen for HT29 but not for HeLa spheroids (Mikhail et al., 2013) .
With the SK-OV-3TR cells, however, spheroids with dense structure and sharp edges could not be prepared. The resulting spheroids were loose aggregates as reported in different studies Kubbies, 2007, Vinci et al., 2012) . SK-OV-3TR cells formed aggregates rather than spheroids with liquid overlay and hanging drop methods as reported previously (Sodek et al., 2009 ) and they were not suitable for handling as the aggregate structure was easily disturbed with pipetting or even adding media into the wells. Recently Loessner et al. (Loessner et al., 2010) and Vinci et al. (Vinci et al., 2012) reported that with hanging drop or liquid overlay method, SK-OV-3 cells can be formed into spheroids with the addition of synthetic hydrogels or Matrigel™ displaying key features of ECM. However, in our study we decided not to use this kind of hydrogel based materials to minimize the possibility of interference with the cytotoxicity and visualization studies, eliminate the additional steps that have crucial effect on spheroid structure. Thus, we used liquid overlay method for the reasons that provided above to prepare NCI-ADR-RES ovarian cancer cell spheroids for in vitro studies and SK-OV-3TR ovarian cancer cells for in vivo tumor inhibition studies.
Cellular association and accumulation of the micelles in spheroids
TF is responsible for iron transport into the cells via its receptor (TfR), a receptor overexpressed in many cancer cells than normal cells (Daniels et al., 2012) . Targeting the TfR with nano-sized carriers has been shown to increase the endocytosis of the carriers and thus, enhance the intracellular payload delivery (Choi et al., 2010 , Sahoo et al., 2004 , Shah et al., 2009 . Total micelle association with cells includes the fluorescently labeled micelle fraction attached to the surface receptors and the fraction internalized. Figure 1 represents the mean rhodamine fluorescence intensity increase obtained by flow cytometry after the treatment of monolayers and spheroids with rhodamine-labeled micelles. Empty micelles (non-rhodamine containing micelles) showed no rhodamine intensity increase comparing to control cells, indicating that there is no autofluorescence interference from the micelle materials. 4 hours after the treatment of monolayers, the rhodamine intensity increase was 67.67±3.51% and 74.05±6.10% respectively for non-targeted and targeted micelles. There was no significant difference related to the targeting, which suggests that in monolayers 4 hours of incubation time is enough for non-modified micelles to associate with the cells in same level as TF-targeted ones.
In spheroids, the intensity was increased significantly with longer incubation times (P<0.05). The intensity increase after 4 hours was less than half of that with monolayers, and even after 6 hours the increase was still significantly lower comparing the monolayers, which indicates the limited penetration of the formulations into the spheroid structure thus less cellular association and internalization of the micelles.
Most of the cancer research involving the drug resistance mainly focuses on the biochemical mechanisms, while the physical limitations of drug penetration and association into the tumor tissues in vivo also plays an underestimated but crucial role (Minchinton and Tannock, 2006) . While water-soluble drugs can easily penetrate and distribute into the ECM and tumor tissues, this ability is limited for water insoluble drugs. At the same time, cells that formed spheroids are in close contact with each other and this cell contact can also lead changes in the receptor, protein and gene expression levels of the cells (Oloumi et al., 2002) . This alteration in the already P-gp overexpressing resistant cells like NCI-ADR-RES could easily cause limited association and penetration of water-insoluble drugs into the spheroids because of the efflux pump activity and physical barriers in the spheroids.
The only significant difference related to the TF targeting seen after 6 hours of incubation (P<0.05), indicates that cellular association patterns are completely different than monolayers. In a recent report, Perche et al. showed that micellar encapsulation of doxorubicin could overcome the limited drug uptake in spheroids. Moreover, further modification of these PEG-PE-based micellar nanocarriers by monoclonal anti-nucleohistone autoantibody 2C5 caused deeper penetration of doxorubicin into the spheroids. In our study, the similar results we obtained suggest that, penetration of the micelles into the spheroids can be further increased using the TF as the targeting moiety.
Choi et al. (Choi et al., 2010) indicate that in addition to the TF modification (targeted vs. non-targeted), TF content of the nanocarriers also plays an important role in terms of optimized cellular interaction. In a recent study, Sawant et al. used TF as one of the targeting ligands of the dual targeted system and they underlined the importance of the TF content for optimal ligand density. Our TF content of 0.64 mole % in the formulations is in agreement with their reported results and suggests that TF can be successfully used as a targeting and endocytosis enhancing ligand for better spheroid penetration (Sawant et al., 2013) .
Accumulation of labeled micelles in spheroids
In order to visualize whether the TF-targeted micelles will have better association and penetration into the spheroids, we analyzed distribution of Rh-labeled micelles, non-targeted and targeted with TF, throughout the spheroids by confocal microscopy (Figure 2 ). This evaluation has been reported before as the indirect identifier of nanocarrier penetration into the spheroids (Kim et al., 2010 , Wartenberg et al., 1998 , Ackerman et al., 2008 . The results suggest that, the small size of the micelles allows for the easy penetration into the spheroids as seen in Figure 2A . Both the non-targeted and TF-targeted micelles can be visualized in the layers of the spheroids as can be seen from the Z-stack images. The brightness and contrast settings were kept constant for each image. To evaluate the penetration differences between the formulations and incubation times, maximum pixel intensity (MPI) Z-projections of the stacks were created using Fiji software. MPI creates an output image using the maximum value of each pixel over all images in the stack at the particular pixel location. The corrected pixel densities in the core area of the spheroid sections from Figure 2A were quantified using Fiji software and plotted against the section distance from the apex of the corresponding spheroid. The analysis was carried out through 140 µm depth, however after 100 µm into the spheroid structure, the pixel densities in the core area become very low due to the faltered laser penetration after ~70 µm (Verveer et al., 2007 , Carver et al., 2014 . It can be seen that the profiles of TFtargeted micelles after 4 and 6 hours of incubation were very similar, indicating the saturation of the penetration with TF targeting. Non-targeted micelles after 6 hours of incubation gave similar pixel intensity profile with the targeted micelles all the way through 30 µm, but their penetration reached the maximum level at 40 µm depth into spheroids, while TF-targeted micelles could reach significantly deeper levels. At 50 µm depth, the pixel densities from the core of the spheroids were quantified and plotted ( Figure 2C ). This depth was chosen to make a quantitative comparison since at deeper layers, the lack of laser penetration could bring upon misleading data. For every time point, TF-targeted micelles showed significantly higher rhodamine density compared to non-targeted formulations.
While the flow cytometry analysis did not show significant increase in the fluorescence intensity related to the TF modification until 6 hours of incubation of formulations with spheroids, the confocal imaging results suggest a better penetration into the spheroid structure of TF-modified micelles for every time point. This difference can be explained by the difference between the time needed to penetrate into the spheroid structure and the time needed for cellular association. TF-modified micelles could penetrate inside the spheroid better than the non-modified ones, but the significantly higher cellular association and internalization occurs only after 2 additional hours. We hypothesize that penetration of micelles inside the spheroid occurs through the ECM spacing and tight junctions as well as due to intracellular passage.
The results obtained by flow cytometry (Figure 1 ) and confocal imaging (Figures 2) supports each other and suggests that PEG-PE based micellar nanocarriers are able to penetrate into the spheroid structure with the benefit of their small size, in agreement with previous studies , Kim et al., 2010 , Han et al., 2009 ). Moreover, TFtargeting significantly enhances the micelle penetration into the deeper layers of the spheroids.
Transferrin receptor expression in spheroids
Flow cytometry data showing the TfR levels in monolayers and spheroids are given in Figure 3 . Three, 5 and 8-day-old spheroids were used to better compare the TfR levels in matured spheroids. The FITC-labeled isotype-matched antibody was used as the baseline control and the mean fluorescence increase associated with TfR-bound antibody was calculated. When the spheroids were pre-treated with labeled antibody, the mean fluorescence increase was very low comparing to the isotype control, which can be explained by 'binding site barrier' hypothesis introduced by Weinstein et al (Juweid et al., 1992) , the concept proposing that macromolecular ligands, such as antibodies, could be prevented from penetrating tumors as a consequence of their successful binding to the target receptors on tumor periphery.
As can be seen from the Figure 3 , the fluorescence increase in the monolayers compared to isotype control was 71.8±3.1% higher than that in the spheroids at different days. The TfR expression levels in spheroids compared to monolayer was not significantly lower, although the trend is easily recognizable. TfR is overexpressed in the cancer cells due to the greater iron demand because of fast growth and division. (Daniels et al., 2012 , Gomme et al., 2005 . The cells in the outer layers of the spheroids are actively dividing, while the cells formed the core of the spheroids enter their quiescent phase, which explains the lowering of TfR levels with increased spheroid maturity. The mean fluorescence increase for 3,5 and 8-day-old spheroids was 68.2±4.6%, 64.1±3.8% and 51.7±13.6%, respectively. The differences were not significantly lower than monolayers or each other (unpaired samples, t test, P>0.05) except the pre-treated spheroids thus, we believe the effect related to TfR levels was not a primary factor in the cellular association and penetration of the formulations into spheroids but still has to be considered for other ligands or systems.
Cytotoxicity in Monolayers
In vitro ability of micelle formulations to deliver PCL and CUR into the cells was assessed in NCI-ADR-RES monolayers. The response of the cells to PCL or CUR as single agents is shown in Figure 4 . Both free drugs, PCL and CUR, showed significantly less cytotoxicity than micellar formulations, and the cell viability response to modified or non-modified micelles were almost the same at all concentrations that were used. Similar to the cellular association results by flow cytometry, the long incubation times with micelle formulations allow them to interact with the cells and be internalized by them, regardless of their modification with a targeting moiety. On the other hand, clear advantage of micellar encapsulation can also be seen from the figures. IC 50 values were 2.01, 1.22 and 1.21 µM for PCL solution, non-modified and TF-modified micelles, respectively. Similar response was obtained for CUR with IC 50 values of 17.37, 10.36 and 10.29 µM for CUR solution, non-modified and TF-modified micelles.
NCI-ADR-RES ovarian cancer cell line is reported to overexpress drug efflux pump P-gp (Dong et al., 2009 , Patil et al., 2009 , Ludwig et al., 2006 and designated as MDR cell line. Thus, micellar encapsulation, in some extent helps to bypassing the P-gp efflux and delivers the drug inside of the MDR cells, as reported by different authors using different micellar structures (Batrakova and Kabanov, 2008 , Kabanov et al., 2002 , Dabholkar et al., 2006 , Li et al., 2010 . For PCL and CUR co-delivery as free drugs, 5 and 20 µM CUR concentrations were kept constant and cells were treated as monolayers with various PCL concentrations. For combinations with 5 µM CUR, cell viability values were same as free PCL, since the CUR did not have any cytotoxic effect at that concentration. Combination with 20 µM CUR resulted in insignificant cell viabilities at every PCL concentrations since the saturation of the cytotoxic effect, around 24% (data not shown).
Cell viability results for co-delivered micellar drugs were given in Figure 5 . Co-loaded micelles with 20 µM CUR, regardless of the PCL concentration and TF modification, caused the same amount of cell death. All viability values at these combination concentrations were below 10%, approximately 15% lower than that of the free drug combinations at the same concentrations. 5 µM CUR micelles (targeted or non-targeted) did not show any cytotoxicity by themselves. While varying the concentration of PCL in the co-loaded micelles and keeping the CUR concentration constant at 5 µM, the combination delivery resulted in significantly higher toxicity compared to PCL micelles alone. The IC 50 value for nonmodified and TF-modified PCL micelles dropped from 1.22 to 0.64 and 1.21 to 0.67 respectively, without significant difference related to TF modification. Approximately 2-fold decrease in the amount of PCL required to achieve a similar cytotoxic outcome was observed for monolayers. Only at 0.80 µM PCL concentration, the combination treatment with both targeted and non-targeted micelles resulted in significantly higher toxicity (synergistic) compared to additive toxicity of individual micelles. At other PCL concentrations the effect was either additive or antagonist (Figure 6 ). It was explained and exemplified in a review by Dicko et al. that depending on the concentrations or ratios of the combined drugs in nanocarriers, the final in vitro or in vivo effect could be synergistic, additive or even antagonistic (Dicko et al., 2010, Mayer and Janoff, 2007) .
Cytotoxicity in Spheroids
To investigate the cytotoxic effects of anticancer drugs on spheroids, several different endpoint tests as colony formation assays (Watanabe et al., 2007 , Mikhail et al., 2013 , live/ dead cell identification with membrane permeable and impermeable dyes (Shin et al., 2013) , LDH release assays , Ho et al., 2012 , Howes et al., 2007 or spheroid size determination assays (Hirschhaeuser et al., 2010 , Kim et al., 2010 were establish and used in studies. Even though spheroid visualization and diameter measurement is one of the most popular techniques mentioned above, it does not necessarily mean that cell death and spheroid integrity reflect and correspond the viable cell numbers in the spheroids. In our study, we found that 72 hours after the treatment mean spheroid diameters were between 530 and 411 µm for all groups, without a clear significant difference between the drug loaded formulations within each other, whether they were modified with TF or not. This result led us to evaluate the influence of adding TF as a targeting moiety with respect to cell viability on the CUR and PCL co-loaded micelles (Figure 7 ) using the CellTiter-Glo ® Luminescent Cell Viability Assay. This assay quantifies the amount of ATP present as an indicator of metabolically active cells i.e. live cells and is proven to be sensitive, reproducible and robust (Vinci et al., 2012 , Lin et al., 2011 , Han et al., 2007 , Fey and Wrzesinski, 2012 . Figure 7 represents the cell viability data obtained by spheroids treated with different formulations and free drugs. As can be seen from the figure, free CUR did not exert any cytotoxicity on spheroids even at a high dose as 40 µM. It should be noted that, in monolayer experiments, free CUR IC 50 value was 17.37 µM and CUR concentrations that have no effect on cell viability were below 5 µM, meaning that 8 times higher doses of CUR did still not cause cell death in spheroids. Free PCL by itself at 6.9 µM caused 80.5±22.0% cell viability in spheroids, while in monolayers significantly lower dose as 0.80 µM caused same viability. When spheroids treated with combination of free drugs at the given concentrations (40 µM CUR and 6.9 µM PCL) spheroid viability was 83.4±10.0%, which is not significantly different than the PCL cytotoxicity as single agent due to the ineffectiveness of CUR.
In terms of micellar single drug delivery into the spheroids, it was shown that the micellar CUR has no cytotoxic effects on spheroids at 20 and 40 µM doses. Viability values of spheroids treated with micellar PCL were 67.3±4.9% and 57.2±1.1% (P<0.05) at 3.45 and 6.9 µM of PCL concentration, respectively. This increase in the cytotoxicity suggests that micellar encapsulation enhance the cellular uptake and penetration into the spheroids over free drugs, in accordance with published studies (Kim et al., 2009 , Kim et al., 2010 . The high concentrations of the micellar drugs to obtain the mentioned cell death values were significantly higher than the doses used in the monolayer experiments. Even though penetration of drugs into a spheroid is the main rate limiting step for effective drug delivery, altered signaling pathways due to the cell-cell contact and microenvironment such as PI3K/Akt and NF-κB plays and important role in the resistance to many drugs by the negatively regulating the apoptosis, increasing the cell survival and overexpressing the P-gp. Despite the increase in the cytotoxicity with micellar drug encapsulation and delivery into spheroids compering the free drugs, the IC 50 values of both micellar CUR and PCL were still 9.3 and 7.3 times more than monolayer IC 50 values.
The addition of TF as the targeting ligand did not have any effect of the toxicity of the CURloaded micelles. IC 50 values were 97.18 and 97.02 µM for non-modified and TF-modified CUR micelles, respectively. On the other hand, we did notice that at 3.45 and 6.9 µM of micellar PCL, the viability decreased from 67.3±4.9% and 57.2±1.1% for the non-targeted formulation to 41.0±5.5% and 35.3±2.7% for the TF-targeted formulation, respectively. At the same time a significant decrease from 8.92 µM to 1.35 µM in the IC 50 values of micellar PCL was observed with TF targeting. This significant increase in the cytotoxicity shows that TF-modification of the micelles can further increase their cytotoxicity against spheroids by deeper penetration into the spheroids and at the same time better cellular uptake and accumulation by the individual cells forming spheroids, also in accordance with the previously published data using antibodies as the targeting moiety . More interestingly, cytotoxicity enhancement over PCL micelles by TF-targeted micelles is 1.64 and 1.62 fold higher at 3.45 and 6.9 µM concentrations, which is almost identical to fluorescence data represented in Figure 3 .
With respect to the CUR and PCL co-delivery treatments shown in Figure 7 , when CUR was combined with PCL, we did notice a significant decrease in cell viability, from 67.3±4.9% to 51.8±2.7% at 20 µM CUR and 3.45 µM PCL, and from 57.2±1.1% to 43.9±5.9% at 40 µM CUR and 6.9 µM PCL. There are numerous reports showing increased P-gp overexpression and related drug resistance in spheroids compared to monolayers in various cancer cell lines including breast, lung and ovarian ones (Doublier et al., 2012 , Kolchinsky and Roninson, 1997 , Ponce de Leon and Barrera-Rodriguez, 2005 , Walker et al., 2004 . It has been shown earlier that co-delivery of anticancer agents with resistance modifiers (Patil et al., 2009 , Patel et al., 2011 , Wong et al., 2006 , Sarisozen et al., 2012a or therapeutic siRNA molecules (Salzano et al., 2014) in nanocarrier formulations could enhance the cytotoxicity and reverse the MDR on 2D monolayers.
Moreover, TF receptor and thus TF targeted nanocarriers have been shown as an important targeted and effective formulations against various 2D cancer cell lines cultures (Daniels et al., 2012 , Daniels et al., 2006 , and even have the potential to reverse MDR in P-gp overexpressing cells (Kobayashi et al., 2007) . In the current study, in accordance with the previous findings, we found that the addition of TF to the single agent-loaded micelles can also increase their activity. On the other hand, TF modification of the CUR and PCL coloaded micelles did not have any significant effects on the viability of 3D resistant cancer cell spheroid. Conversely, the difference in the viability values of spheroids treated with TFtargeted PCL micelles, non-targeted co-loaded micelles and TF-targeted co-loaded micelles were not significant (P>0.05). This finding suggests that TF-modification is able to enhance the effect of PCL loaded micelles to an extent of co-loading with CUR, while it has no effect on co-loaded micelles. Co-loading of PCL and CUR into the micelles or modifying the only PCL loaded micelles with TF is equally effective in resistant ovarian cancer cell spheroid model. We have showed that PCL and CUR co-loading into the micelles is sufficient enough for optimum cytotoxicity without any need of TF modification.
It has been reported that nanoparticles larger than 100 nm were restricted to the spheroid periphery, while smaller 20 nm and 40 nm nanoparticles could effectively penetrate into the spheroid structure (Goodman et al., 2007, Ng and . Moreover, collagenase modification of these nanocarriers further increased their penetration properties due to the matrix modulating enzyme activity (Goodman et al., 2007) . Our results suggest that micelles with ca.20 nm size and modified with TF as endocytosis enhancer and targeting ligand, allow us to achieve good penetration into the spheroid structure without using any ECM modifier enzymes, as proved with flow cytometry, confocal imaging and cytotoxicity experiments. Moreover, we also demonstrated that co-loading of CUR along with PCL into the micelle structure is also a successful approach to overcome MDR in spheroids, due to the previously reported (Aggarwal, 1995 , Shishodia et al., 2005 , Shakibaei et al., 2007 PI3K/Akt and NF-κB inhibitor effect of CUR.
PS externalization and apoptosis enhancement
We investigated the level of the apoptosis in the spheroids after the treatment in order to evaluate the effect of micellar nanocarrier system and drug co-loading. Staining with annexin V was used as the marker for early apoptosis of the cells with intact cell membrane. The translocation of PS from the inner side of the membrane to the outer surface of the membrane allows annexin V to bind and thus make the apoptotic cells recognizable for flow cytometry experiments via its fluorophore tag. PI was used as the second dye to distinguish the cells with damaged membrane, i.e. necrotic and dead cells. The representative dot plots of the double stained cell populations were given in Figure 8A . In the quadrants, lower left side indicates the normal i.e. non-apoptotic cells. Early apoptotic thus annexin V stained cells and late apoptotic (double stained) cells were in the upper left and upper right side, respectively.
The data given in Figure 8 suggests that treatment with empty and CUR loaded micelles causes apoptosis in some extent. But it should be kept in mind that, 8 days after the seeding early apoptosis became evident due to starting of necrotic core formation. PCL loaded micelles on the other hand caused significantly higher early and late apoptotic cells ( Figure  8A ). When the spheroids treated with co-loaded micelle formulations, we observed significant increase in the late apoptotic cell ratio (upper right quadrant in Figure 8A ) and small but significant decrease in the early apoptotic cells ( Figure 8B ). These results could suggest that co-loaded micelles resulted more cell death than apoptosis, indicating that addition of CUR accelerate the response to the cytotoxic PCL by regulating the MDR related mechanisms.
Tumor inhibition studies
We have shown that CUR co-loading enhanced the cytotoxicity of PCL on the resistant ovarian cancer spheroids, but the TF-targeting did not result in any further increase in cytotoxicity of co-loaded formulations. To determine whether it is possible to compare the in vitro data with in vivo and investigate the TF-targeting effect in vivo, we have used PCL/CUR co-loaded and TF-targeted PCL/CUR co-loaded micelles. Empty micelles and TF-empty micelles were chosen as control groups for these studies. At the doses chosen, the formulations produced no toxicity in vivo as indicated by no significant decrease in body weight throughout the study (data not shown). The main objective of the in vivo study was to investigate the TF-targeting effect on the co-loaded micelles and evaluate the possible correlation between the responses of resistant ovarian cancer cell spheroids and live tumors. PEG-PE-based micelles have been shown to easily accumulate in the solid tumors due to the "passive targeting" via the EPR effect, and their ability to stay longer times in the circulation has been reported (Lukyanov et al., 2002 , Weissig et al., 1998 .
At the end of the in vivo study, the tumor volume of the "empty micelle" group reached 1000 mm 3 at day 60. As can be seen from the Figure 9A , the tumor growth patterns of the Empty and TF-Empty micelle groups were similar, even though the volumes were slightly smaller in the TF-modified group. According to the 2-way ANOVA (Bonferroni post-test was applied), tumor volumes between the "empty" and "TF-empty" micelle groups were significantly different only at day 58 and 60 (P<0.01). The combination treatment has exhibited superior tumor growth inhibition, suggesting that combining the anticancer effect of PCL with resistance reversal effect of CUR is a promising approach, even at low PCL dose at 10 mg/kg. On the other hand, TF modification of the co-loaded micelles did not cause significant decrease in the tumor volumes, in accordance with the data obtained from spheroid cytotoxicity experiments. At the end of the in vivo studies, the tumors were excised and weighed. The "combination treatment" tumor weights for both TF-modified and nonmodified groups were significantly lower compared to control drug-free groups ( Figure 9B ).
We have found that the results obtained from tumor inhibition and tumor weight studies correlated well with the spheroid toxicity data presented in Figure 7 . Even though targeting with TF did not enhance the anticancer activity of the formulations, this translation of data from the 3D in vitro assay to the in vivo model was an encouraging outcome. Moreover, we demonstrated in both spheroid and in vivo resistant ovarian cancer model that, when CUR and PCL co-loaded into the micelles TF modification did not further enhance the cytotoxicity and tumor inhibition over non-targeted micelles. Recently, similar results with PCL and Elacridar co-loaded and 2C5 mAb-targeted micelles have been reported (Sarisozen et al., 2012b) . Obtained results shows that we can eliminate the additional steps like conjugation of ligand to the lipid and further dialysis that could cause drug leakage from micelles for preparing TF-targeted micelles, since the same in vitro and in vivo activity could be achieved when PCL and CUR co-loaded in the micelles.
Conclusion
In the present study, MDR ovarian cancer spheroid model and in vivo tumor model were used to evaluate the efficacy of TF-targeted PCL and CUR co-loaded micelles. We have found in spheroid model that significantly higher doses of the drugs need to be used compared the monolayers, to obtain same levels of cytotoxicity due to the altered cellular pathways, overexpression of P-gp and limited penetration due to the 3D structure. TFtargeting provided clear advantages over non-modified micelles in terms of better penetration and cellular association, and significantly increased the cytotoxicity of single agent-loaded micelles. However, when CUR and PCL co-loaded micelles were used, TFtargeting did not further increase the cytotoxicity, both in spheroids and in vivo tumors. When CUR and PCL co-loaded micelles were used, further TF-targeting becomes unnecessary for this active compound combination, which eliminates additional steps and improves the overall stability of the micelle system. The effect of co-loading and TFtargeting resulted in similar responses in vivo and in the 3D cell culture, which suggests that the spheroid model can be used as an intermediate model for evaluation of co-delivery of anticancer compounds by targeted nanocarriers. % Increase in rhodamine intensity after incubation of monolayers and spheroids with rhodamine-labeled formulations for different time points. Results given as mean ± standard deviation of three independent replications, each n=3, * P<0.05. Penetration of TF-targeted and non-targeted micelles throughout NCI-ADR-RES spheroids. NCI-ADR-RES spheroids were incubated for different time points with the formulations. (A) The distribution of micelles was analyzed by confocal microscopy using Z-stack imaging with 10 µm intervals. Scale bars represents 200 µm. Brightness and contrast were modified but kept constant in each image. (B) Corrected integrated pixel density as an indicator of rhodamine intensity was quantified in the core area of each slice of the spheroids from (A). (C) Mean rhodamine intensity at 50 µm depth of the spheroids after the incubation with the formulations. Error bars represents standard deviation, n=3. *P<0.05 using unpaired t test with Welch's correction. Cell viability of the various formulations against NCI-ADR-RES spheroids. Five spheroids were collected as one replicate to achieve necessary sensitivity (n=3, 15 spheroids, mean ± SD, * P<0.05). In vivo studies with various micellar formulations. Nude mice bearing ~200 mm3 SK-OV-3TR tumors were treated every 3 days at a dose of 25 mg/kg CUR and 10 mg/kg PCL IP starting at day zero. Empty micelle dose was equivalent to the amount of micelle-forming material from the drug-loaded micelle groups. n ≥5 per group and all values are expressed as mean±SEM, * P<0.01, ** P<0.001. SK-OV-3TR tumors were harvested when the average tumor volume in the control group reached 1000 mm3 (Student's two tailed unpaired T-test,
